It’s been over 50 years since Nixon declared a War on Cancer, predicting to end cancer by 1978. Nixon’s declaration of “war” empowered congress to budget billions of dollars for research.
What have we gotten for the hundreds of billions of dollars and five decades of research?
Three Sisters, BRCA1 Mutations, and a Cancer Diagnosis While Pregnant American Association for Cancer Research (AACR)
Carolyn Searles and her sisters all tested positive for a BRCA1 mutation and underwent double mastectomies to reduce their breast cancer risk. Still, Carolyn was diagnosed with breast cancer while 16 weeks pregnant. Last week, they joined a group of Pennsylvania constituents, which included AACR President-Elect Robert H. Vonderheide, MD, DPhil, FAACR, to advocate for NIH funding at the Rally for Medical Research. Learn more about Carolyn’s story and her experience at the Rally.
The post Three Sisters, BRCA1 Mutations, and a Cancer Diagnosis While Pregnant appeared first on American Association for Cancer Research (AACR).
AACR on Campus Poland/Ukraine: Creating New Opportunities for Cancer Care in Ukraine Amid War American Association for Cancer Research (AACR)
Around a hundred early-career clinicians and researchers from Ukraine and Poland attended last month’s AACR on Campus event in Warsaw, held in partnership with the Maria Skłodowska-Curie National Research Institute of Oncology and the Global Medical Knowledge Alliance. At the event, Ukrainian oncologists shared how the war is impacting cancer care in their country and why events like this centered on international collaboration can help.
The post AACR on Campus Poland/Ukraine: Creating New Opportunities for Cancer Care in Ukraine Amid War appeared first on American Association for Cancer Research (AACR).
AACR and Kids Beating Cancer Launch New Grant to Advance Pediatric Leukemia Research American Association for Cancer Research (AACR)
AACR and Kids Beating Cancer have announced a new grant to support pediatric leukemia research, with a particular focus on high-risk acute myeloid leukemia subtypes at the AACR Special Conference in Cancer Research: Bridging Discovery and Clinical Impact in Pediatric Cancer. Through this partnership, the organizations aim to advance understanding of these aggressive diseases and accelerate the development of more effective treatments. AACR and Kids Beating Cancer leaders hope the grant will drive innovative discoveries that improve outcomes for children with cancer and their families.
The post AACR and Kids Beating Cancer Launch New Grant to Advance Pediatric Leukemia Research appeared first on American Association for Cancer Research (AACR).
Shining a Light on Uterine Cancer: Rising Incidence and Mortality, Persistent Inequities American Association for Cancer Research (AACR)
In contrast with many cancers, uterine cancer incidence and mortality are on the rise. The disease, which is leading cause of death among gynecologic cancers in the United States, is also associated with deep racial disparities, disproportionately killing Black women. Elizabeth M. Swisher, MD, the 2026-2028 Chair of the AACR Cancer Prevention Working Group (CPWG) steering committee, discussed risk factors, warning signs, and the urgent need for increased public awareness and research funding.
The post Shining a Light on Uterine Cancer: Rising Incidence and Mortality, Persistent Inequities appeared first on American Association for Cancer Research (AACR).
Editors’ Picks, September 2026: Drug Resistance, Breast Cancer Treatment, COVID-19 and Cancer Care, and More American Association for Cancer Research (AACR)
The September 2026 Editors’ Picks from AACR journals include insights into cancer evolution in leukemia, a strategy for overcoming drug resistance, the impacts of the COVID-19 pandemic on cancer care, an investigational treatment for triple-negative breast cancer, and more.
The post Editors’ Picks, September 2026: Drug Resistance, Breast Cancer Treatment, COVID-19 and Cancer Care, and More appeared first on American Association for Cancer Research (AACR).
The Cancer Aftermath of the 9/11 Attacks on First Responders American Association for Cancer Research (AACR)
In memory of those who lost their lives or families on September 11, 2001, this edition of Cancer Research Catalyst reviews the effects of the attacks and showcases the new research being conducted in the 9/11-responder population.
The post The Cancer Aftermath of the 9/11 Attacks on First Responders appeared first on American Association for Cancer Research (AACR).
AI skin cancer detection tools are getting better – but only for people with light skin Health – The Conversation
These apps and software programs could provide access to lifesaving screening – if researchers can find a way to remove the baked-in bias.
A Reminder: Smoking Still Causes Cancer American Association for Cancer Research (AACR)
Recent reporting and rumors may have one believe that cigarettes are cool and popular again among young Americans. The data don’t bear this out—fewer young people smoke than ever—but a reminder of smoking’s dangers nevertheless feels warranted.
The post A Reminder: Smoking Still Causes Cancer appeared first on American Association for Cancer Research (AACR).
Unboxing Cancer News, August 2026: Fishy Cancer, Federal- vs. Industry-funded Trials, and More American Association for Cancer Research (AACR)
Cancer Research Catalyst has launched a new monthly series, “Unboxing Cancer News,” that highlights exciting cancer research discoveries. Read the first installment and learn about transmissible cancer in catfish, federal- vs. industry-sponsored trials, symptoms that may predict early-onset colorectal cancer, and engineered yeast that produce ingredients to make chemotherapy drugs.
The post Unboxing Cancer News, August 2026: Fishy Cancer, Federal- vs. Industry-funded Trials, and More appeared first on American Association for Cancer Research (AACR).
FDA approves breakthrough pancreatic cancer drug – an oncologist explains how daraxonrasib nearly doubles survival Health – The Conversation
Around 97% of patients with advanced pancreatic cancer die within five years. Researchers have figured out a way to target the mechanism that makes these tumors so deadly.